Specific risk factors for microbleeds and white matter hyperintensities in Alzheimer's disease

Neurobiology of Aging

Volumn 34, Issue 11, 2013, Pages 2488-2494

  Benedictus, Marije R ^a   Goos, Jeroen D C ^a   Binnewijzend, Maja A A ^b   Muller, Majon ^b   Barkhof, Frederik ^b   Scheltens, Philip ^a   Prins, Niels D ^a   van der Flier, Wiesje M ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; ApoE; Microbleeds; Microhemorrhage; Risk factors; Small vessel disease; White matter hyperintensities

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E4;

AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRAIN HEMORRHAGE; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HOMOZYGOSITY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; VASCULAR AMYLOIDOSIS; WHITE MATTER HYPERINTENSITY; WHITE MATTER INJURY;

ALZHEIMER'S DISEASE; APOE; MICROBLEEDS; MICROHEMORRHAGE; RISK FACTORS; SMALL VESSEL DISEASE; WHITE MATTER HYPERINTENSITIES;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANALYSIS OF VARIANCE; APOLIPOPROTEIN E4; CEREBRAL HEMORRHAGE; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LEUKOENCEPHALOPATHIES; MAGNETIC RESONANCE IMAGING; MALE; PEPTIDE FRAGMENTS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84881550846     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.04.023     Document Type: Article

References (42)

1. Attems J., Jellinger K., Thal D.R., Van Nostrand W. Review: sporadic cerebral amyloid angiopathy. Neuropathol. Appl. Neurobiol. 2011, 1:75-93.
2. Basile A.M., Pantoni L., Pracucci G., Asplund K., Chabriat H., Erkinjuntti T., Fazekas F., Ferro J.M., Hennerici M., O'Brien J., Scheltens P., Visser M.C., Wahlund L.O., Waldemar G., Wallin A., Inzitari D. Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes. The LADIS (Leukoaraiosis and Disability in the Elderly) Study. Cerebrovasc. Dis. 2006, 5-6:315-322.
3. Boche D., Zotova E., Weller R.O., Love S., Neal J.W., Pickering R.M., Wilkinson D., Holmes C., Nicoll J.A. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain. Brain 2008, 131:3299-3310.
4. Bouwman F.H., Schoonenboom S.N., van der Flier W.M., van Elk E.J., Kok A., Barkhof F., Blankenstein M.A., Scheltens P. CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment. Neurobiol. Aging 2007, 7:1070-1074.
5. Brown W.R., Thore C.R. Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol. Appl. Neurobiol. 2011, 1:56-74.
6. Charidimou A., Gang Q., Werring D.J. Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J.Neurol. Neurosurg. Psychiatry 2012, 2:124-137.
7. Cordonnier C., van der Flier W.M., Sluimer J.D., Leys D., Barkhof F., Scheltens P. Prevalence and severity of microbleeds in a memory clinic setting. Neurology 2006, 9:1356-1360.
8. Cordonnier C., van der Flier W.M. Brain microbleeds and Alzheimer's disease: innocent observation or key player?. Brain 2011, 134:335-344.
9. de la Torre J.C. Vascular basis of Alzheimer's pathogenesis. Ann. N.Y. Acad. Sci. 2002, 977:196-215.
10. de la Torre J.C. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol. 2004, 3:184-190.
11. Decarli C. Vascular factors in dementia: an overview. J.Neurol. Sci. 2004, 1-2:19-23.
12. Dierksen G.A., Skehan M.E., Khan M.A., Jeng J., Nandigam R.N., Becker J.A., Kumar A., Neal K.L., Betensky R.A., Frosch M.P., Rosand J., Johnson K.A., Viswanathan A., Salat D.H., Greenberg S.M. Spatial relation between microbleeds andamyloid deposits in amyloid angiopathy. Ann. Neurol. 2010, 4:545-548.
13. Ellis R.J., Olichney J.M., Thal L.J., Mirra S.S., Morris J.C., Beekly D., Heyman A. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Neurology 1996, 6:1592-1596.
14. Fazekas F., Chawluk J.B., Alavi A., Hurtig H.I., Zimmerman R.A. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am. J. Roentgenol. 1987, 2:351-356.
15. Fazekas F., Kleinert R., Offenbacher H., Schmidt R., Kleinert G., Payer F., Radner H., Lechner H. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993, 9:1683-1689.
16. Goos J.D., Kester M.I., Barkhof F., Klein M., Blankenstein M.A., Scheltens P., van der Flier W.M. Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition. Stroke 2009, 11:3455-3460.
17. Goos J.D., Henneman W.J., Sluimer J.D., Vrenken H., Sluimer I.C., Barkhof F., Blankenstein M.A., Scheltens P.H., van der Flier W.M. Incidence of cerebral microbleeds: a longitudinal study in a memory clinic population. Neurology 2010, 24:1954-1960.
18. Goos J.D., Teunissen C.E., Veerhuis R., Verwey N.A., Barkhof F., Blankenstein M.A., Scheltens P., van der Flier W.M. Microbleeds relate to altered amyloid-beta metabolism in Alzheimer's disease. Neurobiol. Aging 2011, 33:1011.e1-1011.e9.
19. Gouw A.A., Seewann A., Vrenken H., van der Flier W.M., Rozemuller J.M., Barkhof F., Scheltens P., Geurts J.J. Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology. Brain 2008, 131:3286-3298.
20. Gouw A.A., Seewann A., van der Flier W.M., Barkhof F., Rozemuller A.M., Scheltens P., Geurts J.J. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J.Neurol. Neurosurg. Psychiatry 2011, 2:126-135.
21. Gray F., Dubas F., Roullet E., Escourolle R. Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy. Ann. Neurol. 1985, 1:54-59.
22. Greenberg S.M., Vernooij M.W., Cordonnier C., Viswanathan A., Al-Shahi Salman R., Warach S., Launer L.J., van Buchem M.A., Breteler M.M. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009, 2:165-174.
23. Haglund M., Englund E. Cerebral amyloid angiopathy, white matter lesions and Alzheimer encephalopathy - a histopathological assessment. Dement. Geriatr. Cogn. Disord. 2002, 3:161-166.
24. Jellinger K.A. Alzheimer disease and cerebrovascular pathology: an update. J.Neural Transm. 2002, 5-6:813-836.
25. Kalaria R.N. Small vessel disease and Alzheimer's dementia: pathological considerations. Cerebrovasc. Dis. 2002, 13(Suppl 2):48-52.
26. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 7:939-944.
27. Park J.H., Seo S.W., Kim C., Kim G.H., Noh H.J., Kim S.T., Kwak K.C., Yoon U., Lee J.M., Lee J.W., Shin J.S., Kim C.H., Noh Y., Cho H., Kim H.J., Yoon C.W., Oh S.J., Kim J.S., Choe Y.S., Lee K.H., Lee J.H., Ewers M., Weiner M.W., Werring D.J., Na D.L. Invivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment. Ann. Neurol. 2013, 10.1002/ana.23845.
28. Pasquier F., Leys D., Weerts J.G., Mounier-Vehier F., Barkhof F., Scheltens P. Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur. Neurol. 1996, 5:268-272.
29. Pettersen J.A., Sathiyamoorthy G., Gao F.Q., Szilagyi G., Nadkarni N.K., St George-Hyslop P., Rogaeva E., Black S.E. Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study. Arch. Neurol. 2008, 6:790-795.
30. Poels M.M., Vernooij M.W., Ikram M.A., Hofman A., Krestin G.P., van der Lugt A., Breteler M.M. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study. Stroke 2010, 10(Suppl):S103-S106.
31. Scheltens P., Barkhof F., Valk J., Algra P.R., van der Hoop R.G., Nauta J., Wolters E.C. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. Brain 1992, 115:735-748.
32. Scheltens P., Barkhof F., Leys D., Wolters E.C., Ravid R., Kamphorst W. Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging. Neurology 1995, 5:883-888.
33. Scheltens P., Launer L.J., Barkhof F., Weinstein H.C., van Gool W.A. Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability. J.Neurol. 1995, 9:557-560.
34. Sperling R.A., Jack C.R., Black S.E., Frosch M.P., Greenberg S.M., Hyman B.T., Scheltens P., Carrillo M.C., Thies W., Bednar M.M., Black R.S., Brashear H.R., Grundman M., Siemers E.R., Feldman H.H., Schindler R.J. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement. 2011, 4:367-385.
35. Sperling R., Salloway S., Brooks D.J., Tampieri D., Barakos J., Fox N.C., Raskind M., Sabbagh M., Honig L.S., Porsteinsson A.P., Lieberburg I., Arrighi H.M., Morris K.A., Lu Y., Liu E., Gregg K.M., Brashear H.R., Kinney G.G., Black R., Grundman M. Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis. Lancet Neurol. 2012, 3:241-249.
36. Tomimoto H., Akiguchi I., Akiyama H., Ikeda K., Wakita H., Lin J.X., Budka H. Vascular changes in white matter lesions of Alzheimer's disease. Acta Neuropathol. 1999, 6:629-634.
37. van der Flier W.M., Barkhof F., Scheltens P. Shifting paradigms in dementia: toward stratification of diagnosis and treatment using MRI. Ann. N.Y. Acad. Sci. 2007, 1097:215-224.
38. Vernooij M.W., van der Lugt A., Ikram M.A., Wielopolski P.A., Niessen W.J., Hofman A., Krestin G.P., Breteler M.M. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology 2008, 14:1208-1214.
39. Vinters H.V. Cerebral amyloid angiopathy. A critical review. Stroke 1987, 2:311-324.
40. Vinters H.V., Wang Z.Z., Secor D.L. Brain parenchymal and microvascular amyloid in Alzheimer's disease. Brain Pathol. 1996, 2:179-195.
41. Viswanathan A., Greenberg S.M. Cerebral amyloid angiopathy in the elderly. Ann. Neurol. 2011, 6:871-880.
42. Weller R.O., Boche D., Nicoll J.A. Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy. Acta Neuropathol. 2009, 1:87-102.